Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis measured with disease and symptom specific questionnaires.
Phase of Trial: Phase II
Latest Information Update: 04 Jan 2017
At a glance
- Drugs Nintedanib (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 04 Jan 2017 New trial record